rs530478036
Variant summary
Our verdict is Likely benign. The variant received -1 ACMG points: 1P and 2B. PM2_SupportingBP4BS3_Supporting
This summary comes from the ClinGen Evidence Repository: The NM_000152.5:c.658G>T variant is GAA is a missense variant that is predicted to result in the substitution of valine by leucine at amino acid 220 (p.Val220Leu). The highest population minor allele frequency in gnomAD v2.1.1 is 0.00075 (15/19928 alleles) in the East Asian population which is lower than the ClinGen LSD VCEP threshold (<0.001) for PM2_Supporting, meeting this criterion (PM2_Supporting). When expressed in COS-7 cells, this variant results in normal GAA activity, and the protein is normally synthesized and/or processed (PMID 22644586) (BS3_Supporting). The computational predictor REVEL gives a score of 0.305 which is below the threshold of 0.5, evidence that does not predict a damaging effect on GAA function. No impact on splicing is predicted by SpliceAI (BP4). The variant has been reported in an individual with either suspected Pompe disease or a known carrier, but further details are not available (PMID 22644586). There is a ClinVar entry for this variant (Variation ID: 255365). While there is conflicting evidence, overall, the benign evidence, including functional studies (BS3_Supporting) and in silico data (BP4), outweighs the pathogenic evidence (PM2_Supporting). Therefore, the variant has been classified as likely benign. GAA-specific ACMG/AMP criteria met, based on the specifications of the ClinGen Lysosomal Diseases VCEP (Specifications Version 2.0): PM2_Supporting, BP4, BS3_Supporting (modified classification: likely benign, approved by ClinGen Lysosomal Diseases Variant Curation Expert Panel, April 4, 2023). LINK:https://erepo.genome.network/evrepo/ui/classification/CA8814955/MONDO:0009290/010
Frequency
Consequence
NM_000152.5 missense
Scores
Clinical Significance
Conservation
Publications
- glycogen storage disease IIInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, ClinGen, Labcorp Genetics (formerly Invitae), G2P, Laboratory for Molecular Medicine
- glycogen storage disease due to acid maltase deficiency, infantile onsetInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- glycogen storage disease due to acid maltase deficiency, late-onsetInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -1 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000152.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GAA | MANE Select | c.658G>T | p.Val220Leu | missense | Exon 3 of 20 | NP_000143.2 | P10253 | ||
| GAA | c.658G>T | p.Val220Leu | missense | Exon 4 of 21 | NP_001073271.1 | P10253 | |||
| GAA | c.658G>T | p.Val220Leu | missense | Exon 3 of 20 | NP_001073272.1 | P10253 |
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GAA | TSL:1 MANE Select | c.658G>T | p.Val220Leu | missense | Exon 3 of 20 | ENSP00000305692.3 | P10253 | ||
| GAA | TSL:1 | c.658G>T | p.Val220Leu | missense | Exon 4 of 21 | ENSP00000374665.3 | P10253 | ||
| GAA | c.-144G>T | 5_prime_UTR_premature_start_codon_gain | Exon 2 of 19 | ENSP00000519344.1 | A0AAQ5BHE1 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152242Hom.: 0 Cov.: 34 show subpopulations
GnomAD2 exomes AF: 0.0000817 AC: 20AN: 244662 AF XY: 0.0000676 show subpopulations
GnomAD4 exome AF: 0.0000461 AC: 67AN: 1453252Hom.: 0 Cov.: 56 AF XY: 0.0000526 AC XY: 38AN XY: 722900 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152242Hom.: 0 Cov.: 34 AF XY: 0.0000672 AC XY: 5AN XY: 74384 show subpopulations
Age Distribution
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at